NYSEIndustrialsConsulting ServicesSnapshot 2026-08-31
Reading EFX? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Warn: Primary pillar under pressure — Maintain revenue near $6.75B in 2026: FY26 revenue guidance $6.71B-$6.78B vs ~$6.75B target.
Equifax grows revenue about 11-14% yearly, with $6.75B revenue guided for 2026. Profit per share is expected near $8.54 in 2026, showing solid earnings. The company has a strong credit position and stable management. Its valuation is cheaper than peers, offering upside potential.
Revenue growth could slow below 11%, hurting earnings. Profit margins may compress if costs rise. Credit agreement changes could limit financial flexibility. The sector faces headwinds, and analyst revisions have been mostly down recently.
The market prices in about 12% revenue growth and values shares roughly 11% below our fair value near $197. Our fair value is about 10% below the Street median, reflecting a cautious view versus peers.
Breaks if: Credit agreement imposes significant financial constraints
Breaks if: EPS falls below $7.5 in FY26
Breaks if: Revenue falls below $6.0B in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on innovation and consistent revenue growth. The current thesis state is intact, supported by recent strong financial performance and management's commitment to growth priorities.
The market appears to price EFX as cheap compared to its peers, with a low expectations gap. The valuation is justified, indicating that the market does not expect significant negative surprises in the near term.
Fundamentals are likely to remain strong, driven by management's focus on double-digit revenue growth and capital returns to shareholders. However, there is a near-term risk of missing earnings estimates, which could impact sentiment.
The thesis hinges on the performance of sector bellwethers like BAH, FCN, and HURN. If these companies continue to perform well, it could provide a favorable backdrop for EFX. Conversely, any negative guidance from these peers could pose risks.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports a positive outlook. Strong revenue growth and new product innovation reinforce the 2026 revenue growth guidance. There are no new threats impacting the thesis.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, EFX's performance will depend on its ability to maintain growth and navigate sector dynamics. Not investment advice.
